2.315
Immunitybio Inc (IBRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
59.99%
26.43
|
16.52 | 6.106 | 1.047 | 0.04 |
Cost Of Revenue |
134.48%
0.136
|
0.058 | - | - | - |
Gross Profit |
59.72%
26.29
|
16.46 | - | - | - |
Operating Expenses |
20.63%
97.57
|
80.89 | 86.36 | 100.38 | 95.24 |
Interest Income/Expense |
1.05%
15.47
|
15.31 | 29.32 | 29.79 | 29.48 |
Benefits Costs and Expenses |
18.91%
118.73
|
146.42 | 91.86 | 135.63 | 134.17 |
Costs And Expenses |
20.71%
97.71
|
80.95 | 91.86 | 135.63 | 134.17 |
Operating Income/Loss |
10.64%
-71.28
|
-64.43 | -80.25 | -99.33 | -95.20 |
Nonoperating Income/Loss |
67.89%
-21.02
|
-65.47 | -5.499 | -35.25 | -38.93 |
Income/Loss From Continuing Operations Before Tax |
28.94%
-92.31
|
-129.90 | -85.75 | -134.58 | -134.13 |
Income Tax Expense/Benefit |
214.96%
0.269
|
-0.234 | - | - | - |
Income/Loss From Continuing Operations After Tax |
28.61%
-92.57
|
-129.67 | -85.75 | -134.58 | -134.13 |
|
28.61%
-92.57
|
-129.67 | -85.75 | -134.58 | -134.13 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
5.00%
-0.019
|
-0.02 | -0.023 | -0.02 | -0.021 |
Basic Average Shares |
4.11%
888.22
|
853.16 | 695.89 | 686.94 | 672.83 |
Diluted Average Shares |
4.11%
888.22
|
853.16 | 697.96 | 686.94 | 672.83 |
Basic Earnings Per Share |
33.33%
-0.10
|
-0.15 | -0.12 | -0.20 | -0.20 |
Diluted Earnings Per Share |
33.33%
-0.10
|
-0.15 | -0.14 | -0.20 | -0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):